Opinion

Video

Future Directions in mCRPC

Panelists discuss how the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) is rapidly evolving through advancements in precision medicine and novel therapies, while emphasizing the importance of ongoing education for community oncologists to stay updated on these changes.

Related Videos
1 expert is featured in this series.
Medcast series
1 expert is featured in this series.
1 expert is featured in this series.
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.